A Study of JNJ-80202135 in Healthy Chinese Adult Participants
Status:
Not yet recruiting
Trial end date:
2022-07-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetic (PK) of nipocalimab following
single intravenous (IV) administration in healthy Chinese participants.